Market Place
Sourcing Support
Sound Pharma Announces Positive Phase 3 Meniere’s Disease Results
10 Dec 2024 //
BUSINESSWIRE
Sound Pharma Completes Phase 3 Study Of SPI-1005 For Meniere`s
31 Jul 2024 //
BUSINESSWIRE
Sound Pharmaceuticals’ IND Involving Cochlear Implantation Allowed by the FDA
20 May 2024 //
BUSINESSWIRE
Sound Pharma to present positive data from Ph 2b Cystic Fibrosis STOP Trial
30 Jan 2024 //
PR NEWSWIRE
Sound Pharma initiates enrollment in pivotal PIII trial of SPI-1005
28 Jul 2022 //
PRNEWSWIRE
Sound Pharma`s NIH Grant for COVID-19 treatment increases to $4.2M
11 May 2022 //
PRNEWSWIRE
Sound Pharmaceuticals to launch NIH-funded Covid-19 oral therapeutic trial
07 Apr 2021 //
CLINICALTRIALSARENA
Sound Pharmaceuticals awarded $3.1M NIH grant to test SPI-1005 in COVID-19
06 Apr 2021 //
PRNEWSWIRE
Sound Pharmaceuticals Receives $3.1M NIH Grant for COVID Treatment
06 Apr 2021 //
CONTRACTPHARMA
FDA allows Sound Pharmaceuticals to test SPI-1005 as treatment for COVID-19
31 Aug 2020 //
BIOSPACE
Sound Pharmaceuticals files IND to test SPI-1005 in Phase 2 COVID-19 trials
30 Jul 2020 //
PRNEWSWIRE
Sound Pharma advances pivotal Phase 3 clinical trials in Meniere`s Disease
08 Jun 2020 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.